MXCT: MaxCyte Inc

MXCT新闻

• 14:05 Cellares appoints Ali Soleymannezhad as chief commercial officer
• 00:11 MaxCyte, Inc. (MXCT) Q3 2025 Earnings Call Transcript
• 21:17 MaxCyte CFO Douglas Swirsky to step down in first half of 2026
• 22:25 Avidity Biosciences, Inc. (RNA) Reports Q3 Loss, Beats Revenue Estimates
• 13:05 ANI Pharmaceuticals (ANIP) Q3 Earnings and Revenues Beat Estimates
• 00:10 Masoud Maher buys Maxcyte (MXCT) shares worth $102,915
• 00:07 Maxcyte CFO Swirsky buys $64.5k in shares
• 23:54 Brooke William buys Maxcyte (MXCT) shares worth $64,500
• 23:51 Douglas buys $111k in Maxcyte shares
• 23:49 Erck Stanley C, Maxcyte director, buys $137k in MXCT stock
• 12:00 This C3.ai Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday - C3.ai (NYSE:AI), Aspen Aerogels (NYSE:ASPN)
• 10:53 MaxCyte stock rating downgraded to Neutral by BTIG on funding concerns
• 08:48 MaxCyte stock downgraded by William Blair to Market Perform on weak guidance
• 22:10 MaxCyte, Inc. (MXCT) Reports Q2 Loss, Misses Revenue Estimates
• 21:30 MaxCyte Q3 2025 presentation slides: SPL portfolio expands despite market challenges
• 21:13 MaxCyte to delist shares from London AIM, maintains Nasdaq listing
• 06:35 MaxCyte stockholders approve AIM delisting, company to trade only on Nasdaq
• 21:06 MaxCyte shareholders approve equity plan expansion, AIM delisting
• 06:22 MaxCyte and Ori Biotech partner to enhance cell therapy manufacturing
• 12:30 MaxCyte: Strong Revenues, Fast-Growing Cell-Therapy Market (NASDAQ:MXCT)
• 12:36 Hello Group, loanDepot, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Lazard (NYSE:LAZ), Amylyx Pharmaceuticals (NASDAQ:AMLX)
• 23:52 MaxCyte, Inc. (MXCT) Q4 2024 Earnings Call Transcript
• 21:28 MaxCyte shares tumble as Q4 revenue plunges despite beating estimates